Recently, FBXW7 was shown to mediate the ubiquitination and degradation of EGFR, influencing the efficacy of EGFR inhibitors in human CRC-derived organoid lines (Boretto et al., 2024; Nemecek et al., 2016). This evidence concerns the gene EGFR and colorectal carcinoma.